Skip to main content

Datatrak International, Inc. to Exhibit at SCOPE Summit 2020

Written by Customer Service on . Posted in Public Companies.

CLEVELAND, Feb. 11, 2020 (GLOBE NEWSWIRE) — via NEWMEDIAWIRE — Datatrak International, Inc. (OTC Markets: DTRK), a worldwide Software-as-a-Service (SaaS) provider and innovation leader of cloud-based technologies for the Life Sciences industry, today announced it will be exhibiting the Datatrak Enterprise Cloud at the 11th Annual SCOPE Summit in Orlando FL (Booth #612).  Datatrak product experts will be on hand providing product demonstrations of the Enterprise Cloud Platform including Business Intelligence, CTMS, EDC, Image Capture and Centralized Endpoint Adjudication, ePRO, eCOA and eConsent.
“The Annual SCOPE Summit provides Datatrak an opportunity to connect with Clinical Operations & Research Executives to showcase the value our technology platform offers in reducing the operational costs of integrating redundant stand-alone systems,” said Scott DeMell, VP Sales at Datatrak.“The focus of the Annual SCOPE Summit on driving innovation in clinical trials and digital health, and the fact that the Datatrak Enterprise Cloud eliminates point solutions and provides an integrated platform managed by a single vendor, aligns perfectly with the audience,” said Jim Bob Ward, CEO and President of Datatrak.  “We are excited for the opportunity to engage with the SCOPE attendees, as we continue to expand the collection of data directly from patients and provide clients with a platform for Virtual Trials.”  Over 2,000 participants will gather at the Hyatt Regency Orlando, in Orlando, FL, February 18-21, 2020 for 4 days of in-depth discussions covering important issues in clinical trial planning and management. Book an appointment with Datatrak at SCOPE (Booth #612) in Orlando to see the Datatrak Enterprise Cloud Platform. Click HereSee the release on the website: https://bit.ly/2vlBmmZAbout Datatrak International, Inc.:Datatrak International is a worldwide technology and services company delivering unified eClinical solutions and related services for the clinical trials industry. Datatrak built its multi-component, comprehensive solution on a single, unified platform. The Company delivers a complete portfolio of software products designed to accelerate the reporting of clinical research data from sites to sponsors and ultimately regulatory authorities, faster and more efficiently than loosely integrated technologies. The Datatrak software solution, deployed worldwide through an ASP or Enterprise Transfer offering, supports Pre-clinical, Phase I – Phase IV drug, device and diagnostic studies in multiple languages throughout the world.The Datatrak Enterprise Cloud includes the following products: Business Intelligence, CTMS, Trial Design, Electronic Data Capture (EDC), Medical Coding, Risk-Based Monitoring, ECG Data Capture, Image Data Capture, Endpoint Adjudication, Randomization, Clinical Supply Inventory, eConsent, ePRO, and eCOA.Scott DeMell
4404430082
scott.demell@datatrak.com

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.